Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...

Earlier this year, J.P. Morgan released a report outlining the potential for GLP-1 treatments in other markets. Specifically, ...

Researchers found that the study cohort had a significantly lower risk for suicidal ideation or attempts during 12 months of follow-up.

Biologists at Brown University have discovered how a neuropeptide hormone made in the gut of flies can control their lifespan ...

In recent years, the pharmaceutical industry has witnessed a remarkable surge in the development of weight loss medications.

USA: A recent narrative review has highlighted the effectiveness of GLP-1 receptor agonists (RAs) in treating type 2 diabetes ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?